ext-Generation Therapy for NK/T-cell lymphoma in East Asia: a multi-institutional retrospective study
Not Applicable
- Conditions
- Extranodal NK/T-cell lymphoma, nasal type (ENKL)
- Registration Number
- JPRN-UMIN000015491
- Lead Sponsor
- Department of Hematology and Oncology, Mie University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detailed information on treatment, clinical features and prognosis of patients with ENKL who were treated with next-generation therapy in Japan Construct a prognostic model among patients with ENKL who were treated with next-generation therapy
- Secondary Outcome Measures
Name Time Method Toxicity profile of next-generation therapy in Japan Clinical features and prognosis of patients with ENKL who were diagnosed between 2000 and 2013 in Japan